Laronde

Cambridge, United States

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.

$440.0M raised

Aug 2021

Series B

Top Investors

BlackRockFidelityFlagship PioneeringInvusCPP Investments

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Laronde raised?

Laronde has raised $440.0M in total funding. The most recent round was Series B. The last funding was announced in August 2021.

Who are Laronde's investors?

Laronde's investors include BlackRock, Fidelity, Flagship Pioneering, Invus, CPP Investments.

Where is Laronde headquartered?

Laronde is headquartered in Cambridge, United States.

What does Laronde do?

Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body.

What stage is Laronde at?

Laronde is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 30, 2021.

MLA

"Laronde — Funding & Investors." VCBacked, August 30, 2021, https://www.vcbacked.co/company/laronde. Accessed July 1, 2026.

APA

VCBacked. (2021). Laronde — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/laronde

Wikipedia (cite web)

{{cite web |title=Laronde — Funding & Investors |url=https://www.vcbacked.co/company/laronde |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 30, 2021.